Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

<p><span style="background-color:transparent;">The&nbsp;<i>All of Us&nbsp;</i>Research Program seeks to advance its mission by enabling access to biospecimens stored in the&nbsp;<i>All of Us&nbsp;</i>supported Biobank for researchers to conduct assays to evaluate associations between biomarkers and chronic diseases and add data to the<i> All of Us</i> resource for broad use by researchers. Biomarker analysis includes, but is not limited to, biomarker discovery; biomarker validation; novel disease stratification; and multiomics integration for disease risk, diagnosis, and prognosis, in support of advancing precision medicine. The&nbsp;<i>All of Us&nbsp;</i>Research Program is a historic effort to enroll 1 million participants who share data to accelerate research and medical breakthroughs, and enable individualized prevention, treatment, and care. Researchers use data from the program to learn more about how individual differences in lifestyle, environment, and genetics can influence health and disease.</span><br><br><span style="background-color:transparent;">Grant authorities that allow the&nbsp;<i>All of Us</i> Research Program to forecast this opportunity are as follows: 42 USC 241 and 284.</span></p>